Sensex drops 732 points; investors lose ₹6.5 lakh crore in a day— 10 key highlights from the Indian stock market today
The Sensex closed 721 points, or 0.88 per cent, down at 81,463.09, while the Nifty 50 settled 225 points, or 0.90 per cent, lower at 24,837.
The market saw an overall sell-off, and the mid- and small-cap segments ended with even deeper losses. The BSE Midcap index declined 1.46 per cent, while the Smallcap index crashed 1.88 per cent.
Investors lost nearly ₹ 6.5 lakh crore in a single day as the cumulative market capitalisation of BSE-listed firms dropped to nearly ₹ 451.7 lakh crore from ₹ 458.11 lakh crore in the previous session.
Weak earnings, delayed India-US trade deal, relentless foreign capital outflow amid stretched valuation of the domestic market are the key factors behind the market's downtrend.
"Subdued corporate results and lacklustre global cues triggered a broad-based sell-off across domestic equities. Elevated valuations in large-cap stocks, coupled with significant net short positions held by FIIs, added to the downward pressure," Vinod Nair, Head of Research, Geojit Investments, observed.
"Investor sentiment remained fragile amid ongoing uncertainty over US-India tariff negotiations and the ECB maintaining the status quo, with rate cuts deferred until clearer insights emerge on the inflationary impact of trade developments. Moderation in DII inflows after the strong buying of the last two to three months, due to a muted earnings season and persistent FII selling, continues to impact the current market," said Nair.
Only seven stocks managed to end in the green in the Nifty 50 index, among which Cipla (up 3.17 per cent), SBI Life Insurance Company (up 2.07 per cent), and Apollo Hospitals (up 1.50 per cent) stood at the top.
Shares of Bajaj Finance (down 4.81 per cent), Shriram Finance (down 3.64 per cent), and IndusInd Bank (down 2.64 per cent) ended as the top losers in the index.
Barring Nifty Healthcare (up 0.69 per cent) and Pharma (up 0.54 per cent), all sectoral indices ended with losses, with Media (down 2.61 per cent), Oil & Gas (down 1.96 per cent), PSU Bank (down 1.70 per cent), and Metal (down 1.64 per cent) losing heavily.
Nifty Bank dropped 0.94 per cent, while the Financial Services ended 0.88 per cent lower.
Jayaswal Neco Industries (34.72 crore shares), Vodafone Idea (23.83 crore shares), and Ola Electric Mobility (13.61 crore shares) were the most active stocks in terms of volume on the NSE.
Defying weak market sentiment, 15 stocks, including The Phosphate Company, Aashka Hospitals, Sharda Cropchem, Kellton Tech Solutions, Sharika Enterprises, and Vimta Labs, surged over 10 per cent on the BSE.
B-Right Realestate, Eighty Jewellers, Jonjua Overseas, and Hexaware Technologies were among the seven stocks that crashed more than 10 per cent on the BSE.
Out of 4,154 stocks traded on the BSE, 1,116 advanced, while 2,893 declined. Some 145 stocks remained unchanged.
While the stock market ended with significant losses, as many as 111 stocks, including ICICI Bank, eClerx Services, Home First Finance Company India, Laurus Labs, Sai Life Sciences, Shyam Metalics and Energy, and Torrent Pharmaceuticals, hit their 52-week highs in intraday trade.
Praveen Dwarakanath, Vice President of Hedged.in, pointed out that the Nifty sharply fell from its resistance of 25,200 and closed near its support at 24,800, indicating a possible bounce in the index from the current level.
Dwarakanath further highlighted that the index has closed near the lower Bollinger band, a support from which can push the index upside.
The momentum indicators in today's fall have entered the oversold region, which can also push the markets upward from current levels.
Dwarakanath also said the index is at a strong weekly buy level between 24,600 and 24,800. A bounce from this level can present a strong selling opportunity near the 25,200 levels.
Read all market-related news here
Read more stories by Nishant Kumar
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
35 minutes ago
- Mint
Stock to buy: Anand Rathi predicts Apollo Micro Systems' share price to rise 25% in 3 months. Here's why
Stock to buy: Indian brokerage firm Anand Rathi Investment Services disclosed its bullish stance on Apollo Micro Systems shares, predicting a 25% upside in the upcoming three-month period. In the stock report, Anand Rathi analysts highlighted that the shares of the Aerospace and Defence equipment maker had undergone a 'significant correction' after peaking near the ₹ 221 levels. They also stated that the stock is now moving 'within its Ichimoku cloud,' aligning with the previous breakout zone. 'The stock is moving within its Ichimoku cloud, aligning with the previous breakout zone, while the 100-day Exponential Moving Average (DEMA) also corresponds closely to this area. Fibonacci retracement levels between 38.2% and 50% further indicate potential support, suggesting a base formation near the 165-175 range,' said the analysts at Anand Rathi. On the technical front, the shares' Relative Strength Index (RSI) is hovering over the 40 support mark, which likely indicates a potential stabilisation. 'Additionally, the daily Relative Strength Index (RSI) is around the crucial 40 support mark, signalling possible stabilisation,' they said. Apollo Micro Systems Ltd (APOLLO): Buy in the range of ₹ 165-175; Target Price at ₹ 210; Stop Loss at ₹ 150 (on a daily closing basis). 'Given this technical setup, investors might consider buying or accumulating shares within the 165-175 zone. The upside target is projected at 210, while a stop-loss below 150 on a daily closing basis is recommended to manage risk. This outlook highlights key support and resistance levels that traders should monitor closely before making investment decisions,' recommended Jigar Patel, Senior Manager of Equity Research at Anand Rathi Share and Stock Brokers, in the stock report. Apollo Micro Systems shares closed 0.29% higher at ₹ 172.30 after Friday's stock market session, compared to ₹ 171.80 at the previous market close. The brokerage firm released its bullish stance on the company after market operating hours last week, on 25 July 2025. Shares of the Aerospace and Defence equipment maker have given stock market investors more than 1,280% returns on their investment in the last five years and over 39% gains in the last one-year period. On a year-to-date (YTD) basis, the stock has jumped 40.87% in 2025 but are currently trading 4.7% lower in the last five market sessions on the Indian stock market. According to data collected from the BSE website, Apollo Micro Systems shares hit their 52-week high at ₹ 221.40 on 24 June 2025, while the 52-week low was at ₹ 88.10 on 23 October 2024. The shares are currently trading under their year-high levels. The company's market capitalisation (M-Cap) stood at ₹ 5,280.82 crore as of the stock market close on Friday, 27 July 2025. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
India.com
an hour ago
- India.com
No Entry For GM Crops, Says New Delhi; India-US Trade Talks Hit A Sacred Wall
New Delhi: Genetically modified (GM) crops will not be crossing India's borders anytime soon, no matter how urgently the United States knocks. As trade negotiations between New Delhi and Washington enter a crucial phase, insiders say one red line is not up for discussion. 'There are things that are not about negotiation. Some things are a matter of principle,' said a senior official close to the development. That principle, sources say, is GM corn and soy. While American negotiators have made agricultural access a central demand, pressing India for a wider entry gate for U.S. farm goods, New Delhi is not blinking, especially on GM imports. Over the years, the issue has mutated from a mere trade disagreement into a symbolic fight over sovereignty, food safety and grassroots politics. The United States Trade Representative (USTR) has repeatedly flagged India's restrictions on GM products, calling them 'non-tariff barriers'. But Indian authorities remain unmoved, largely because of the hardline stance taken by domestic groups closely aligned with the ruling establishment. Last month, the message from Sangh affiliates was if America insists on forcing GM crops into the Indian market, there may be no trade deal at all. Carried in Business Standard, that warning echoed the sentiments of influential groups such as the Bharatiya Kisan Sangh (BKS) and the Swadeshi Jagran Manch (SJM), which have long opposed agricultural concessions to Washington, particularly in sectors like dairy and GM crops. Their argument? Food security. The BKS has often warned that allowing U.S. crops into India, especially without clear labelling or transparency, could sabotage domestic farming ecosystems and compromise health safety standards. On the other hand, the SJM sees this as a direct attack on economic self-reliance. Meanwhile, the clock is ticking. U.S. officials have privately hinted at the urgency of the moment, pointing to a deadline set by President Donald Trump, who is seeking a revival of his trade agenda. Trump has marked August 1 as a red-letter day. If no interim deal is inked by then, India could be hit with reciprocal tariffs, potentially as high as 26 percent. Indian trade negotiators are not indifferent to that pressure. But according to officials involved in the process, the sixth round of talks will only happen in the second half of August after Trump's deadline expires. Any hope for a short-term resolution seems, at best, unrealistic. As one official put it, 'We are not looking at compromise in areas that touch the lives of millions.' In other words, GM corn is off the table. And perhaps, so is the deal, at least for now.
Mint
3 hours ago
- Mint
Lenskart receives shareholder nod to raise ₹2,150 crore via IPO: Report
Lenskart IPO: Peyush Bansal-led Indian eyewear company Lenskart has received the approval of its shareholder to raise ₹ 2,150 crore through a fresh issue of shares, reported MoneyControl, citing people aware of the development. According to news report, the company filed its corporate action development with the Ministry of Corporate Affairs' (MCA) Registrar of Companies (RoC), as per the data accessed by TheKredible. The proposal to raise money via an IPO was reportedly given the green light at the company's annual general meeting on 26 July 2025, said the report, adding, the eyewear company is expected to file its draft red herring prospectus (DRHP) with the capital markets regulator, the Securities and Exchange Board of India (Sebi), in the upcoming days. The overall IPO size is expected to be around $1 billion or ₹ 8,500 crore, which includes a secondary offer-for-sale (OFS) component by the existing investors, the report added. Earlier this month, Mint reported that the eyewear company's founder, Peyush Bansal, is looking to buy a 1.5-2% stake in the eyewear retailer worth about $150 million from existing investors ahead of its planned IPO. Peyush is buying small stakes from a bunch of investors. This is being negotiated at around $7-8 billion valuation. Existing investors like TR Capital, Chiratae, Softbank and Kedaara Capital are expected to sell their stake as part of the deal. Over the years, the company has raised $1.08 billion in funding across 19 rounds, including its latest Series I round for $18.2 million on 21 July 2023. It has received investments from various firms, including SoftBank Vision Fund, TPG, and Chiratae Ventures. Kotak Mahindra Capital, Axis Capital, Citi, Morgan Stanley, and Avendus Capital are the company-appointed book-runners for the IPO, which is soon expected to hit Dalal Street. The company was founded in 2010, and since then, it has emerged as one of the biggest players in the Indian eyewear industry. It has 2500 retail outlets across the nation and a presence globally, such as in Singapore and the United Arab Emirates (UAE).
